JP4088151B2 - Ｇａｂａａ受容体モデュレーターとしてのベンゾジアゼピン誘導体 - Google Patents

Ｇａｂａａ受容体モデュレーターとしてのベンゾジアゼピン誘導体 Download PDF

Info

Publication number
JP4088151B2
JP4088151B2 JP2002543495A JP2002543495A JP4088151B2 JP 4088151 B2 JP4088151 B2 JP 4088151B2 JP 2002543495 A JP2002543495 A JP 2002543495A JP 2002543495 A JP2002543495 A JP 2002543495A JP 4088151 B2 JP4088151 B2 JP 4088151B2
Authority
JP
Japan
Prior art keywords
benzodiazepine
triazolo
imidazo
ethyl
oxadiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002543495A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004517070A (ja
JP2004517070A5 (https=
Inventor
マスツィアドリ，ラファエロ
トーマス，アンドリュー・ウィリアム
ヴィッヒマン，ユルゲン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2004517070A publication Critical patent/JP2004517070A/ja
Publication of JP2004517070A5 publication Critical patent/JP2004517070A5/ja
Application granted granted Critical
Publication of JP4088151B2 publication Critical patent/JP4088151B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2002543495A 2000-11-16 2001-11-08 Ｇａｂａａ受容体モデュレーターとしてのベンゾジアゼピン誘導体 Expired - Fee Related JP4088151B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16
PCT/EP2001/012887 WO2002040487A2 (en) 2000-11-16 2001-11-08 Benzodiazepine derivatives as gaba a receptor modulators

Publications (3)

Publication Number Publication Date
JP2004517070A JP2004517070A (ja) 2004-06-10
JP2004517070A5 JP2004517070A5 (https=) 2005-05-26
JP4088151B2 true JP4088151B2 (ja) 2008-05-21

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002543495A Expired - Fee Related JP4088151B2 (ja) 2000-11-16 2001-11-08 Ｇａｂａａ受容体モデュレーターとしてのベンゾジアゼピン誘導体

Country Status (40)

Country Link
US (1) US6743789B2 (https=)
EP (1) EP1337535B1 (https=)
JP (1) JP4088151B2 (https=)
KR (1) KR100504300B1 (https=)
CN (1) CN1191255C (https=)
AR (1) AR031345A1 (https=)
AT (1) ATE268776T1 (https=)
AU (2) AU1700702A (https=)
BG (1) BG107817A (https=)
BR (1) BR0115393A (https=)
CA (1) CA2427576C (https=)
CZ (1) CZ295256B6 (https=)
DE (1) DE60103776T2 (https=)
DK (1) DK1337535T3 (https=)
EC (1) ECSP034607A (https=)
ES (1) ES2220831T3 (https=)
GC (1) GC0000375A (https=)
GT (1) GT200100230A (https=)
HR (1) HRP20030360A2 (https=)
HU (1) HUP0303281A3 (https=)
IL (1) IL155813A0 (https=)
JO (1) JO2359B1 (https=)
MA (1) MA26962A1 (https=)
MX (1) MXPA03004251A (https=)
MY (1) MY141675A (https=)
NO (1) NO324706B1 (https=)
NZ (1) NZ525413A (https=)
PA (1) PA8532401A1 (https=)
PE (1) PE20020583A1 (https=)
PL (1) PL362925A1 (https=)
PT (1) PT1337535E (https=)
RU (1) RU2278865C2 (https=)
SI (1) SI1337535T1 (https=)
SK (1) SK7232003A3 (https=)
TR (1) TR200402073T4 (https=)
TW (1) TWI239333B (https=)
UY (1) UY27026A1 (https=)
WO (1) WO2002040487A2 (https=)
YU (1) YU35603A (https=)
ZA (1) ZA200303435B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
JP4616770B2 (ja) * 2003-06-19 2011-01-19 第一三共株式会社 選択的なアミノ置換基導入法
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2577060A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
WO2006040038A1 (en) * 2004-10-12 2006-04-20 F.Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
ES2399439T3 (es) * 2004-10-20 2013-04-01 F. Hoffmann-La Roche Ag Derivados de imidazo-benzodiazepina
AU2005299031B2 (en) * 2004-10-20 2011-11-10 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
BRPI0515800A (pt) 2004-12-14 2008-08-05 Hoffmann La Roche imidazo-benzodiazepinas tetracìclicas como moduladores de receptores de gaba
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
KR101009860B1 (ko) * 2005-10-11 2011-01-19 에프. 호프만-라 로슈 아게 이미다조 벤조다이아제핀 유도체
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US9156836B2 (en) * 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
KR101385433B1 (ko) * 2008-11-18 2014-04-14 에프. 호프만-라 로슈 아게 다이하이드로테트라아자벤조아줄렌의 알킬사이클로헥실에터
HRP20131067T1 (hr) * 2008-11-28 2013-12-06 F. Hoffmann - La Roche Ag Arilcikloheksileteri od dihidrotetraazabenzoazulena za primjenu kao antagonista receptora vazopresina v1a
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
EP3034079B1 (en) 2010-11-15 2018-01-10 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CA2885148A1 (en) * 2012-09-21 2014-03-27 Uwm Research Foundation, Inc. Novel gabaa agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma
EP3083569B1 (en) * 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP6987384B2 (ja) * 2015-06-19 2021-12-22 エージンバイオ， インコーポレイテッド ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
US11414425B2 (en) 2018-06-19 2022-08-16 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (https=) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
MY141675A (en) 2010-06-15
ATE268776T1 (de) 2004-06-15
HUP0303281A3 (en) 2005-05-30
MA26962A1 (fr) 2004-12-20
PA8532401A1 (es) 2002-08-26
DE60103776T2 (de) 2005-07-14
CN1191255C (zh) 2005-03-02
PT1337535E (pt) 2004-09-30
CA2427576C (en) 2007-11-06
BG107817A (bg) 2004-07-30
CN1474820A (zh) 2004-02-11
NO324706B1 (no) 2007-12-03
WO2002040487A3 (en) 2002-09-26
AR031345A1 (es) 2003-09-17
CA2427576A1 (en) 2002-05-23
EP1337535A2 (en) 2003-08-27
RU2278865C2 (ru) 2006-06-27
CZ20031597A3 (cs) 2003-11-12
DK1337535T3 (da) 2004-10-25
HRP20030360A2 (en) 2005-04-30
AU1700702A (en) 2002-05-27
DE60103776D1 (de) 2004-07-15
RU2003116895A (ru) 2005-02-20
AU2002217007B2 (en) 2006-11-30
KR100504300B1 (ko) 2005-07-28
ES2220831T3 (es) 2004-12-16
GC0000375A (en) 2007-03-31
IL155813A0 (en) 2003-12-23
HUP0303281A2 (hu) 2004-01-28
SI1337535T1 (en) 2004-10-31
ZA200303435B (en) 2004-08-05
UY27026A1 (es) 2002-06-20
YU35603A (sh) 2006-05-25
US20020103371A1 (en) 2002-08-01
JO2359B1 (en) 2006-12-12
SK7232003A3 (en) 2004-03-02
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
EP1337535B1 (en) 2004-06-09
CZ295256B6 (cs) 2005-06-15
ECSP034607A (es) 2003-06-25
PE20020583A1 (es) 2002-07-06
NO20032208D0 (no) 2003-05-15
JP2004517070A (ja) 2004-06-10
NO20032208L (no) 2003-05-15
TWI239333B (en) 2005-09-11
BR0115393A (pt) 2004-07-06
MXPA03004251A (es) 2003-09-22
PL362925A1 (en) 2004-11-02
US6743789B2 (en) 2004-06-01
WO2002040487A2 (en) 2002-05-23
KR20030045192A (ko) 2003-06-09
HK1062442A1 (en) 2004-11-05
GT200100230A (es) 2002-07-04

Similar Documents

Publication Publication Date Title
JP4088151B2 (ja) Ｇａｂａａ受容体モデュレーターとしてのベンゾジアゼピン誘導体
AU2002217007A1 (en) Benzodiazepine derivatives as GABA A receptor modulators
KR100533406B1 (ko) Ｇａｂａ ａ 수용체 조절제로서의이미다조[1,5-ａ]피리미도[5,4-ｄ]벤즈아제핀 유도체
EP1805184B1 (en) Imidazo-benzodiazepine derivatives
CA2584757C (en) Halogen substituted benzodiazepine derivatives
CN1134437C (zh) 5－位取代的－3－噁二唑基－1，6－二氮杂萘－2（1h）－酮衍生物
HK1116173A (en) Halogen substituted benzodiazepine derivatives

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070515

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080222

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110228

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees